Vertex Pharmaceuticals (NASDAQ: VRTX) net income
Vertex Pharmaceuticals reported a net profit of $3,953m for fiscal 2025; in fiscal 2024 it reported a net loss of $535.6m. Its net margin was 32.9%. Earnings per share were $15.46.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | $3,953m | — | 32.9% | $15.46 |
| 2024 | −$535.6m | −114.8% | −4.9% | −$2.08 |
| 2023 | $3,620m | +9.0% | 36.7% | $14.05 |
| 2022 | $3,322m | +41.8% | 37.2% | $12.97 |
| 2021 | $2,342m | −13.6% | 30.9% | $9.09 |
| 2020 | $2,712m | +130.4% | 43.7% | $10.44 |
| 2019 | $1,177m | −43.9% | 28.3% | $4.58 |
| 2018 | $2,097m | +695.8% | 68.8% | $8.24 |
| 2017 | $263.5m | — | 10.6% | $1.06 |
| 2016 | −$112.1m | — | −6.6% | −$0.46 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Questions about the net income of Vertex Pharmaceuticals
- How much did Vertex Pharmaceuticals earn in fiscal 2025?
- Vertex Pharmaceuticals reported a net profit of $3,953m for fiscal 2025. In fiscal 2024 it reported a net loss of $535.6m.
- What are the earnings per share of Vertex Pharmaceuticals?
- They were $15.46 in fiscal 2025, compared with −$2.08 in fiscal 2024.
- What is the net margin of Vertex Pharmaceuticals?
- In fiscal 2025 its net profit was 32.9% of its revenue.
- What was the most profitable year for Vertex Pharmaceuticals?
- Of its last 10 fiscal years, fiscal 2025, with $3,953m.
- Where do the figures for Vertex Pharmaceuticals come from?
- From the annual report (Form 10-K) that Vertex Pharmaceuticals files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Vertex Pharmaceuticals files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Vertex Pharmaceuticals: the Vertex Pharmaceuticals page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.